A Study of ANAVEX3-71 in Adults With Schizophrenia
Clinical trial NCT06245213 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06245213
- Sponsor
- Anavex Life Sciences Corp.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2025-06-30
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.